- Exhibit & Support
- Hotel & Travel
There is an urgency to treat Persistent Cardiovascular Risk (P-CVR) as it remains high despite statin-based standard-of-care therapy in patients with elevated triglycerides. In this program, we will review data from a practice changing trial that provides a new therapeutic option to elevate the current standard of care.
Speaker: Daniel Hilleman, PharmD
Presented by Amarin